CAT - catalase Gene
Species: Canis lupus familiaris (sub-species: familiaris)
Gene Type: protein coding
Gene ID: 403474
CAT Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001002984.1 | NP_001002984.1 | catalase |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
catalase |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(27)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0988 | Deferoxamine mesylate | 99.86% | Unkown | |
| HY-B1625 | Deferoxamine | 99.76% | Yes | |
| HY-Y0682 | Ethylenediaminetetraacetic acid | 98.29% | Unkown | |
| HY-B0193A | Prazosin hydrochloride | 99.89% | Unkown | |
| HY-75161 | (-)-Menthol | Activator | 99.79% | Unkown |
| HY-P0163 | Gramicidin | Inhibitor | 99.5% | Unkown |
| HY-B1836 | Meldonium | Activator | 99.89% | Unkown |
| HY-B1221 | Flufenamic acid | 99.93% | Unkown | |
| HY-N7075 | Inulin | / | Unkown | |
| HY-109556 | Insulin Detemir | Activator | 95.0% | Unkown |
| HY-B0565 | Ronidazole | Inhibitor | 99.81% | Unkown |
| HY-B1213 | Trimipramine maleate | 99.88% | Unkown | |
| HY-B1203A | Fludrocortisone acetate | 99.59% | Unkown | |
| HY-A0066A | Tolazoline hydrochloride | Antagonist | 99.93% | Unkown |
| HY-B1833 | Afloqualone | Agonist | 99.94% | Unkown |
| HY-B1836A | Meldonium dihydrate | Activator | 99.0% | Unkown |
| HY-B1330 | Proglumide | Antagonist | 99.84% | Yes |
| HY-119572 | Sodium zirconium cyclosilicate | 95.0% | Unkown | |
| HY-B0416 | Gallamine Triethiodide | 99.56% | Unkown | |
| HY-W011602 | Triethyl citrate | 98.93% | Unkown | |
| HY-103354 | Proglumide sodium | Antagonist | 99.58% | Yes |
| HY-W014332 | 1,3-Diphenylguanidine | 99.76% | Unkown | |
| HY-B1009 | Ethylenediaminetetraacetic acid trisodium salt | 98.0% | Unkown | |
| HY-103354A | Proglumide hemicalcium | Antagonist | / | Unkown |
| HY-B0193AR | Prazosin hydrochloride (Standard) | / | Unkown | |
| HY-B1213A | Trimipramine | / | Unkown | |
| HY-B0416R | Gallamine Triethiodide (Standard) | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99053 | Tralokinumab | Inhibitor | 99.12% | Unkown |
Clinical Phase
Bioactive Molecules
(21)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-N6687 | Calcimycin | 99.12% | Phase 4 | |
| HY-113218 | Acetyl-L-carnitine | Inhibitor | 99.86% | Phase 4 |
| HY-B0762 | Acetyl-L-carnitine hydrochloride | Inhibitor | 99.95% | Phase 4 |
| HY-W127774 | EDTA hydrate sodium | 97.0% | Phase 4 | |
| HY-W105700 | Ethylenediaminetetraacetic acid sodium hydrate | 98.0% | Phase 4 | |
| HY-N6687A | Calcimycin hemicalcium salt | / | Phase 4 | |
| HY-N6687B | Calcimycin hemimagnesium | / | Phase 4 | |
| HY-W087947 | EDTA dihydrate tripotassium | 97.0% | Phase 4 | |
| HY-103586 | GS-441524 | Inhibitor | 99.92% | Phase 3 |
| HY-142118 | Trabedersen | Inhibitor | 91.24% | Phase 3 |
| HY-114671 | Taprostene | Agonist | 98.1% | Phase 3 |
| HY-145728 | Alicaforsen | Inhibitor | / | Phase 3 |
| HY-118874 | Oblimersen | / | Phase 3 | |
| HY-103586R | GS-441524 (Standard) | Inhibitor | / | Phase 3 |
| HY-P2141A | TRV-120027 TFA | Agonist | 99.62% | Phase 2 |
| HY-100516 | Cimicoxib | Inhibitor | 98.02% | Phase 2 |
| HY-A0157B | Dimethothiazine hydrochloride | Antagonist | / | Phase 2 |
| HY-P10515 | AcrAP2 | Inhibitor | / | Phase 2 |
| HY-15533 | LY 3000328 | Inhibitor | 99.50% | Phase 1 |
| HY-103586A | GS-441524 hydrochloride | Inhibitor | 99.62% | Phase 1 |
| HY-W160358 | 2,5-Dimethylcyclohexanol | Inhibitor | 99.88% | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99305 | Metelimumab | Inhibitor | 98.98% | Phase 2 |
| HY-P99474 | Bertilimumab | Inhibitor | 97.01% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(339)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-13434 | Ionomycin | 99.27% | Unkown | |
| HY-P1410 | GsMTx4 | Inhibitor | 99.89% | Unkown |
| HY-101840 | EIPA | 99.73% | Unkown | |
| HY-13434A | Ionomycin calcium | 98.32% | Unkown | |
| HY-146245 | ODN 1826 | 99.69% | Unkown | |
| HY-152182 | ML-SA5 | Agonist | 99.69% | Unkown |
| HY-P1410A | GsMTx4 TFA | Inhibitor | 99.85% | Unkown |
| HY-100973A | Adenosine 5′-diphosphoribose sodium | 99.47% | Unkown | |
| HY-101840A | EIPA hydrochloride | 98.01% | Unkown | |
| HY-112540B | Acetoacetic acid sodium | 98.0% | Unkown | |
| HY-129555 | Surfactin | Inhibitor | 98.96% | Unkown |
| HY-100973 | Adenosine 5′-diphosphoribose | 98.21% | Unkown | |
| HY-P1471 | Adrenomedullin (AM) (22-52), human | Antagonist | 99.61% | Unkown |
| HY-B1793 | Tetraethylammonium chloride | Inhibitor | 98.0% | Unkown |
| HY-W011527 | Xanthosine | Activator | 99.99% | Unkown |
| HY-Y1881B | Copper sulfate pentahydrate, for cell culture, 98% | 99.99% | Unkown | |
| HY-112540A | Acetoacetic acid lithium | 98.0% | Unkown | |
| HY-125623 | MitoPerOx | 97.41% | Unkown | |
| HY-113469 | Cyclic GMP | 99.77% | Unkown | |
| HY-19960 | BCTC | 99.66% | Unkown | |
| HY-126752 | Ophthalmic acid | Activator | 99.91% | Unkown |
| HY-Y0682A | Ethylenediaminetetraacetic acid disodium dihydrate | 99.9% | Unkown | |
| HY-113486 | Lathosterol | 99.96% | Unkown | |
| HY-14710 | AZ3146 | Inhibitor | 99.42% | Unkown |
| HY-Y1881A | Copper sulfate pentahydrate, 99.9% | 99.90% | Unkown | |
| HY-D0193 | Ponceau 4R | 99.84% | Unkown | |
| HY-150726 | ODN 1668 | 99.03% | Unkown | |
| HY-128483 | Fusaric acid | 99.94% | Unkown | |
| HY-112540 | Acetoacetic acid | 95.0% | Unkown | |
| HY-120601 | Alizarin Red S sodium | 95.0% | Unkown | |
| HY-100231 | Cathepsin inhibitor 1 | Inhibitor | 99.28% | Unkown |
| HY-N7700A | Guluronic acid sodium | Inhibitor | 98.0% | Unkown |
| HY-P5601A | Thanatin TFA | Inhibitor | 99.68% | Unkown |
| HY-107740 | Pseudoisocyanine iodide | Inhibitor | 99.97% | Unkown |
| HY-32350 | Ercalcitriol | Activator | 99.71% | Unkown |
| HY-122605 | TRPM4-IN-1 | Inhibitor | 99.17% | Unkown |
| HY-129096 | IDT307 | 99.74% | Unkown | |
| HY-W021358 | N,N,N′,N′-Tetramethyl-p-phenylenediamine | 99.98% | Unkown | |
| HY-P2141 | TRV-120027 | Agonist | 98.21% | Unkown |
| HY-148129 | Apecotrep | Inhibitor | 99.17% | Unkown |
| HY-W013579 | (S)-(+)-Carvone | 99.26% | Unkown | |
| HY-135869 | Mito-apocynin (C11) | Inhibitor | 99.84% | Unkown |
| HY-113469A | Cyclic GMP sodium | 99.89% | Unkown | |
| HY-101327A | Xamoterol hemifumarate | Agonist | ≥99.0% | Unkown |
| HY-19408 | Pyr10 | Inhibitor | 99.95% | Unkown |
| HY-110374 | NVS-CECR2-1 | 99.40% | Unkown | |
| HY-B0762S1 | Acetyl-L-carnitine-d3-1 hydrochloride | Inhibitor | 99.12% | Unkown |
| HY-N1378 | (E)-Cardamonin | 99.84% | Unkown | |
| HY-B0762S | Acetyl-L-carnitine-d3 hydrochloride | Inhibitor | 99.79% | Unkown |
| HY-117685 | Cefovecin sodium | Inhibitor | 99.79% | Unkown |
| HY-P2324 | Gramicidin A | Inhibitor | ≥98.0% | Unkown |
| HY-P5601 | Thanatin | Inhibitor | 99.47% | Unkown |
| HY-144256 | CHD1Li 6.11 | 99.54% | Unkown | |
| HY-131897 | 1-Stearoyl-2-arachidonoyl-sn-glycerol | Activator | 99.0% | Unkown |
| HY-146584 | Cathepsin C-IN-5 | Inhibitor | 95.70% | Unkown |
| HY-W018574 | Tetraoctylammonium bromide | 98.0% | Unkown | |
| HY-132280 | Tirilazad | Inhibitor | 98.11% | Unkown |
| HY-B1827 | D-Galacturonic acid hydrate | 99.92% | Unkown | |
| HY-W013762 | Tributyl citrate | 98.33% | Unkown | |
| HY-120601A | Alizarin Red S | 95.0% | Unkown | |
| HY-125870 | Gellan gum, for cell culture | 97.0% | Unkown | |
| HY-159821 | Ulacamten | Inhibitor | 99.22% | Unkown |
| HY-N0631 | Cornuside | Inhibitor | 99.99% | Unkown |
| HY-P2887 | Acetate kinase (ACK) | / | Unkown | |
| HY-W014106 | Tetraethylammonium tetrafluoroborate | ≥98.0% | Unkown | |
| HY-160610A | Carbamoyl phosphate dilithium salt | / | Unkown | |
| HY-W020249 | Sodium ionophore X | 98.0% | Unkown | |
| HY-B0927 | Hydrastine | Inhibitor | 99.57% | Unkown |
| HY-108460 | A-784168 | Inhibitor | 99.79% | Unkown |
| HY-112776A | BN82002 hydrochloride | Inhibitor | 99.36% | Unkown |
| HY-139192 | Brophenexin | 98.74% | Unkown | |
| HY-Y0682S | Ethylenediaminetetraacetic acid-d12 | 99.98% | Unkown | |
| HY-133825 | Cyazofamid | Inhibitor | 98.15% | Unkown |
| HY-121065 | BN-82685 | Inhibitor | 99.05% | Unkown |
| HY-DY1073 | MitoPerOx (solution) | / | Unkown | |
| HY-N2003 | D-Tetrahydropalmatine | Antagonist | 99.84% | Unkown |
| HY-N2368 | Arecaidine | 99.63% | Unkown | |
| HY-B1549 | Lauryl benzalkonium chloride | ≥97.0% | Unkown | |
| HY-B1636 | Dithiazanine iodide | Inhibitor | 99.46% | Unkown |
| HY-D0202 | Arsenazo III | 95.0% | Unkown | |
| HY-P1077A | CALP1 TFA | 98.15% | Unkown | |
| HY-Y0682B | Ethylenediaminetetraacetic acid tetrasodium | Inhibitor | 98.0% | Unkown |
| HY-107835 | Flumethrin | 99.29% | Unkown | |
| HY-B1827A | D-Galacturonic acid | 99.92% | Unkown | |
| HY-E70373 | λ Protein phosphatase | / | Unkown | |
| HY-N6790 | Nonactin | 99.0% | Unkown | |
| HY-W094517 | Sodium phosphate dibasic heptahydrate | 98.74% | Unkown | |
| HY-W339331 | Flubendiamide | Activator | 99.42% | Unkown |
| HY-17630 | Edasalonexent | Inhibitor | 96.05% | Yes |
| HY-P2602 | α-Casozepine | 99.74% | Unkown | |
| HY-W111692 | Sodium polyphosphate, crystal,+200 mesh, 96% | / | Unkown | |
| HY-111527 | PPZ2 | 99.92% | Unkown | |
| HY-171152A | NSC 357754 dihydrochloride | Inhibitor | 98.01% | Unkown |
| HY-B1827R | D-Galacturonic acid hydrate (Standard) | 99.92% | Unkown | |
| HY-N3029 | Noreugenin | Inhibitor | 99.42% | Unkown |
| HY-W006212 | 1,4,7-Triazonane | 99.62% | Unkown | |
| HY-W011087 | Benzyldimethyltetradecylammonium chloride | 99.70% | Unkown | |
| HY-W014408 | Tetraethylammonium bromide | 98.0% | Unkown | |
| HY-76632 | 4-Hydroxyisophthalic acid | Activator | 99.51% | Unkown |
| HY-W103463 | 1-Phenyl-2-pyrrolidinone | Inhibitor | 99.86% | Unkown |
| HY-100634 | 4-Hydroxypropranolol hydrochloride | Antagonist | 99.73% | Unkown |
| HY-107535 | AS1269574 | 99.84% | Unkown | |
| HY-109077 | Tigolaner | 99.37% | Unkown | |
| HY-145150 | TRPC5-IN-1 | Inhibitor | 98.97% | Unkown |
| HY-P1770 | Adrenomedullin (16-31), human | 99.96% | Unkown | |
| HY-158222 | Alginate Methacryloyl (MW 50000) | / | Unkown | |
| HY-46846 | Styrene-divinylbenzene sulfonated copolymer | 98% | Unkown | |
| HY-W013264A | Tetrabutylammonium chloride monohydrate | 97.0% | Unkown | |
| HY-W587415 | cis/trans-Nepetalactol | 95.0% | Unkown | |
| HY-10656 | SB-657510 | Antagonist | 99.84% | Unkown |
| HY-116161A | 17-Phenyl trinor PGF2α isopropyl ester | 99.76% | Unkown | |
| HY-117865 | GNE-886 | Inhibitor | 99.81% | Unkown |
| HY-128383 | 1-Methylpyrrolidine | 99.02% | Unkown | |
| HY-139192A | Brophenexin free base | 99.24% | Unkown | |
| HY-158222A | Alginate Methacryloyl (MW 300000) | / | Unkown | |
| HY-N4309A | Lotusine hydroxide | Inhibitor | 99.56% | Unkown |
| HY-N5073 | Vitexin-4''-O-glucoside | Inhibitor | 99.86% | Unkown |
| HY-P10118A | Cathepsin L-IN-3 TFA | Inhibitor | 98.18% | Unkown |
| HY-W011972 | Bromocholine bromide | 98.0% | Unkown | |
| HY-W015815 | 6-Methylnicotinamide | 99.98% | Unkown | |
| HY-W016638 | 1-Butyl-1-methylpyrrolidinium chloride | 98.0% | Unkown | |
| HY-W753904 | Pradofloxacin | Inhibitor | 98.02% | Unkown |
| HY-B2035 | Pretilachlor | 99.25% | Unkown | |
| HY-W127739 | Zineb | / | Unkown | |
| HY-12761 | A-836339 | Agonist | 99.84% | Unkown |
| HY-113469B | Cyclic GMP TBAOH | / | Unkown | |
| HY-123449 | MK-761 free base | Inhibitor | 99.56% | Unkown |
| HY-131897S | 1-Stearoyl-2-Arachidonoyl-d8-sn-Glycerol | Activator | 99.13% | Unkown |
| HY-135868 | Mito-apocynin (C2) | Inhibitor | 98.38% | Unkown |
| HY-137155 | Dapsone hydroxylamine | Inhibitor | 99.3% | Unkown |
| HY-171657 | 4'-Acetoxy resveratrol | 99.90% | Unkown | |
| HY-B0762R | Acetyl-L-carnitine hydrochloride (Standard) | Inhibitor | 99.95% | Unkown |
| HY-B1221S1 | Flufenamic acid-13C6 | / | Unkown | |
| HY-P1077 | CALP1 | 98.44% | Unkown | |
| HY-RS03139 | CRAT Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W011052 | Tetrapentylammonium bromide | 98.0% | Unkown | |
| HY-W012450 | Trimethylphenylammonium bromide | 98.0% | Unkown | |
| HY-W127701 | [Bmpip][NTf2] | 97.0% | Unkown | |
| HY-W654000 | Cyclic GMP-13C,15N2 | 98.81% | Unkown | |
| HY-W781133 | cDPCP | 99.9% | Unkown | |
| HY-Y0682S1 | Ethylenediaminetetraacetic acid-d16 | 99.1% | Unkown | |
| HY-14830 | SAR 97276 | Inhibitor | 98.05% | Unkown |
| HY-171152 | NSC 357754 | Inhibitor | / | Unkown |
| HY-N19254 | Shepherdine | Inhibitor | / | Unkown |
| HY-N4309 | Lotusine | Inhibitor | 99.91% | Unkown |
| HY-101327 | Xamoterol | Agonist | / | Unkown |
| HY-107345 | Droxicam | Inhibitor | 99.59% | Unkown |
| HY-108446 | GSK 1562590 hydrochloride | Antagonist | 99.0% | Unkown |
| HY-111297 | BMVC4 | / | Unkown | |
| HY-112776 | BN82002 | Inhibitor | / | Unkown |
| HY-113486R | Lathosterol (Standard) | 96.91% | Unkown | |
| HY-149203A | MQA-P TFA | 97.36% | Unkown | |
| HY-153613 | Ac-PLVE-FMK | Inhibitor | 98.0% | Unkown |
| HY-155254 | Sodium ionophore VI | 98.0% | Unkown | |
| HY-161772 | (S)-Gebr32a | Inhibitor | 98.97% | Unkown |
| HY-172342 | MitoA bromide | 99.4% | Unkown | |
| HY-E70012 | Penicillinase | / | Unkown | |
| HY-E70191 | β-1,4-Galactosyltransferase 2 | / | Unkown | |
| HY-N10144 | Shinpterocarpin | Inhibitor | / | Unkown |
| HY-N7700 | Guluronic acid | Inhibitor | 98.90% | Unkown |
| HY-P5898 | Z-Val-Val-Nle-diazomethylketone | Inhibitor | / | Unkown |
| HY-W014536 | N,N,N-Trimethyloctan-1-aminium chloride | 99.0% | Unkown | |
| HY-W073128 | Perfluorotetradecanoic acid | 98.0% | Unkown | |
| HY-W105699 | EDTA tetrasodium tetrahydrate | 97.0% | Unkown | |
| HY-W110904 | Methylthymol blue tetrasodium | / | Unkown | |
| HY-W767865 | Cyclic GMP sodium-13C5 | 99.03% | Unkown | |
| HY-116778 | Prostaglandin G2 | Inducer | 99.9% | Unkown |
| HY-147774 | Cathepsin K inhibitor 6 | Inhibitor | 98.18% | Unkown |
| HY-N11424 | Bilirubin diglucuronide | Substrate | / | Unkown |
| HY-N8707 | Homobutein | Inhibitor | 98.35% | Unkown |
| HY-RS29475 | CEPT1 Human/Cat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W739372 | Polysodium 4-styrenesulfonate | / | Unkown | |
| HY-103586S2 | GS-441524-d | Inhibitor | / | Unkown |
| HY-100057 | BMY 28674 | Antagonist | / | Unkown |
| HY-10290 | MK-0674 | Inhibitor | / | Unkown |
| HY-103216A | RWJ52353 hydrochloride | Agonist | / | Unkown |
| HY-105628 | Prodilidine | / | Unkown | |
| HY-106074 | Mexiprostil | / | Unkown | |
| HY-107129 | MK-3577 | Antagonist | / | Unkown |
| HY-107644 | AQ-RA 741 | Antagonist | / | Unkown |
| HY-107756 | LOE 908 hydrochloride | Inhibitor | / | Unkown |
| HY-107835R | Flumethrin (Standard) | / | Unkown | |
| HY-107835S | Flumethrin-d5 | / | Unkown | |
| HY-110411 | Chlorproethazine hydrochloride | / | Unkown | |
| HY-111525 | Monactin | Inhibitor | / | Unkown |
| HY-113486S1 | lathosterol-d7 | / | Unkown | |
| HY-113778 | 15-keto-17-phenyl trinor Prostaglandin F2α | / | Unkown | |
| HY-114986 | 6-Keto-PGE1 | Inhibitor | 99.0% | Unkown |
| HY-115371 | Butaperazine dimaleate | / | Unkown | |
| HY-116161 | Bimatoprost isopropyl ester | / | Unkown | |
| HY-116264 | CatB-IN-1 | / | Unkown | |
| HY-116478 | L-3373 | Inhibitor | / | Unkown |
| HY-117284A | Eucatropine hydrochloride | Inhibitor | / | Unkown |
| HY-117774 | AHR-2244 hydrochloride | / | Unkown | |
| HY-117817 | Ranelic acid | / | Unkown | |
| HY-118092 | JWU-A021 | Activator | / | Unkown |
| HY-119512 | Ethoxomane | Inhibitor | / | Unkown |
| HY-119925 | Amaralin | / | Unkown | |
| HY-120685 | WAY-125971 | Antagonist | / | Unkown |
| HY-121554 | Kojic amine | / | Unkown | |
| HY-121670 | Ambenoxan | / | Unkown | |
| HY-121670A | Ambenoxan hydrochloride | / | Unkown | |
| HY-123449A | MK-761 TFA | Antagonist | 99.93% | Unkown |
| HY-12392A | Iprindole hydrochloride | Agonist | / | Unkown |
| HY-124514 | UC-857993 | Inhibitor | / | Unkown |
| HY-124894 | (+)-Benalaxyl | Inhibitor | / | Unkown |
| HY-126115 | 15(S)-Latanoprost | Inhibitor | / | Unkown |
| HY-126763 | ATI22-107 | Inhibitor | / | Unkown |
| HY-128383S | 1-Methylpyrrolidine-d8 | / | Unkown | |
| HY-128383S1 | 1-Methylpyrrolidine-d3 | / | Unkown | |
| HY-129846 | IBTP iodide | / | Unkown | |
| HY-136894 | Rhod-5N | / | Unkown | |
| HY-137952 | NS8593 | Inhibitor | / | Unkown |
| HY-138058 | AF-CX 921 | / | Unkown | |
| HY-14360 | MK 1256 | Inhibitor | / | Unkown |
| HY-143714 | Cathepsin K inhibitor 2 | Inhibitor | / | Unkown |
| HY-146580 | Cathepsin C-IN-3 | Inhibitor | / | Unkown |
| HY-146581 | Cathepsin C-IN-4 | Inhibitor | / | Unkown |
| HY-147186 | 5,5'-Difluoro BAPTA | / | Unkown | |
| HY-147333 | Trimipramine N-oxide | / | Unkown | |
| HY-148156 | Hydroxydione | Inhibitor | / | Unkown |
| HY-153614 | Ac-VLPE-FMK | Inhibitor | 99.0% | Unkown |
| HY-156045A | Cross-linked dextran G 10 | / | Unkown | |
| HY-157441 | AChE/Aβ-IN-4 | Inhibitor | / | Unkown |
| HY-157915 | HFPB | / | Unkown | |
| HY-165439 | Indolidan | Inhibitor | / | Unkown |
| HY-165569 | AU-1421 | Modulator | / | Unkown |
| HY-171837A | t9,t11,c15-CLNA | / | Unkown | |
| HY-172387 | CM Cross-linked dextran C 25 | / | Unkown | |
| HY-172387A | CM Cross-linked dextran C 50 | / | Unkown | |
| HY-175498 | RLA-3107 | Inhibitor | / | Unkown |
| HY-178082 | MK-251 | Antagonist | / | Unkown |
| HY-178233 | CAT335 | Activator | / | Unkown |
| HY-178236 | TRPM5 agonist-1 | Inhibitor | / | Unkown |
| HY-179502 | Anti-inflammatory agent 107 | / | Unkown | |
| HY-180141 | AF03 | Activator | / | Unkown |
| HY-180384 | 1,10-Bis(methylsulfinyl)decane | / | Unkown | |
| HY-180396 | Ikarisoside B | / | Unkown | |
| HY-180402 | 1,10-Bis(ethylsulfinyl)decane | / | Unkown | |
| HY-181015 | α-D-Manp(3→1)-α-D-Manp(2→1)-α-D-Glu | / | Unkown | |
| HY-181174 | Antioxidant agent-22 | / | Unkown | |
| HY-181430 | PXS 25 | Inhibitor | / | Unkown |
| HY-182296 | SCH 79687 | Antagonist | / | Unkown |
| HY-182363 | A6CDQ | / | Unkown | |
| HY-182469 | FuBIG | / | Unkown | |
| HY-182537 | Org 9616 bromide | / | Unkown | |
| HY-183268 | TRPM4-IN-4 | Inhibitor | / | Unkown |
| HY-184140 | AChE-IN-117 | Inhibitor | / | Unkown |
| HY-184530A | Flotufolastat Ga | / | Unkown | |
| HY-A0157 | Dimethothiazine | Antagonist | / | Unkown |
| HY-A0157A | Dimethothiazine mesylate | Antagonist | / | Unkown |
| HY-B0565S | Ronidazole-d3 | Inhibitor | / | Unkown |
| HY-B1221S | Flufenamic acid-d4 | / | Unkown | |
| HY-D1640 | 5',5-Difluoro BAPTA tetrapotassium | / | Unkown | |
| HY-D3207 | DHUCu-1 | / | Unkown | |
| HY-D3212 | Crisp-17 | / | Unkown | |
| HY-E70953 | Pyruvate Kinase/Lactic Dehydrogenase enzymes, Rabbit | / | Unkown | |
| HY-E70992 | Eosinophil Peroxidase, Human | / | Unkown | |
| HY-E71164 | 1,5-Anhydro-D-fructose dehydratase | / | Unkown | |
| HY-N13756 | Deoxymikanolide | / | Unkown | |
| HY-N14351 | Ferrocin A | Inhibitor | / | Unkown |
| HY-N17925 | Falandioside B | Inhibitor | / | Unkown |
| HY-N19783 | Carambolaside M | / | Unkown | |
| HY-N6687C | Calcimycin hemicalcium hemimagnesium | / | Unkown | |
| HY-N7857 | 19(R)-Hydroxy-prostaglandin F2α | / | Unkown | |
| HY-P10118 | Cathepsin L-IN-3 | Inhibitor | / | Unkown |
| HY-P10228 | S-Thanatin | Inhibitor | / | Unkown |
| HY-P10652 | hsBCL9CT-24 | Inhibitor | / | Unkown |
| HY-P1471A | Adrenomedullin (AM) (22-52), human TFA | Antagonist | / | Unkown |
| HY-P1770A | Adrenomedullin (16-31), human TFA | / | Unkown | |
| HY-P2324A | Gramicidin A TFA | Inhibitor | / | Unkown |
| HY-P3711 | SPAI-1 | Inhibitor | / | Unkown |
| HY-RS01982 | CAT Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS05510 | GLYAT Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W010736A | 1,2-Dipalmitoyl-rac-glycerol | / | Unkown | |
| HY-W011122 | Tributylbenzylammonium bromide | 98.0% | Unkown | |
| HY-W013231 | N-Benzyl-N,N-diethylethanaminium iodide | / | Unkown | |
| HY-W013803 | Xanthosine dihydrate | Activator | / | Unkown |
| HY-W075836 | Ferrocenylmethyltrimethylammonium iodide | / | Unkown | |
| HY-W699451 | MTSET chloride | Inhibitor | / | Unkown |
| HY-W711474 | (-)-Menthol-d4 | / | Unkown | |
| HY-W724370 | Tetraethylammonium bromide-d20 | / | Unkown | |
| HY-W748419 | Acetylstrophanthidin | / | Unkown | |
| HY-W753904S | Pradofloxacin-d4 | / | Unkown | |
| HY-W765177 | Acetyl-L-carnitine hydrochloride-13C3 | / | Unkown | |
| HY-W773294 | Tetramethylammonium silicate solution | / | Unkown | |
| HY-W777365 | Ethylenediaminetetraacetic acid-13C4 | / | Unkown | |
| HY-W783446A | DACH-Pt-SO4 | Inhibitor | / | Unkown |
| HY-Y0682S2 | Ethylenediaminetetraacetic acid-d4 | / | Unkown | |
| HY-101327AR | Xamoterol hemifumarate (Standard) | Agonist | / | Unkown |
| HY-106699 | Taprostene sodium | Agonist | / | Unkown |
| HY-116889 | 15-Keto latanoprost acid | / | Unkown | |
| HY-122369 | Histargin | Inhibitor | / | Unkown |
| HY-12392R | Iprindole (Standard) | Agonist | / | Unkown |
| HY-126605 | Trinactin | Inhibitor | / | Unkown |
| HY-127147 | Fazadinium bromide | Inhibitor | / | Unkown |
| HY-128383R | 1-Methylpyrrolidine (Standard) | / | Unkown | |
| HY-130325 | α-Guanidinoglutaric acid | Inhibitor | 98% | Unkown |
| HY-134268 | 8-Br-7-CH-ADPR | Antagonist | / | Unkown |
| HY-137639 | Sp-8-Br-cGMPS | Agonist | / | Unkown |
| HY-139120 | 19(R)-hydroxy Prostaglandin E2 | / | Unkown | |
| HY-148034 | Plm IV inhibitor-1 | Inhibitor | / | Unkown |
| HY-157240 | CEX Ion-exchange resin | / | Unkown | |
| HY-157241 | CEX Cation-exchange resin 1 | / | Unkown | |
| HY-157242 | CEX Polishing resin | / | Unkown | |
| HY-157243 | CEX Cation-exchange resin 2 | / | Unkown | |
| HY-161612 | Mycosporine 2 glycine | Inhibitor | / | Unkown |
| HY-163073 | Anti-MRSA agent 9 | Inhibitor | / | Unkown |
| HY-168363 | Ciclotizolam | Ligand | / | Unkown |
| HY-170993 | Antimicrobial agent-39 | Inhibitor | / | Unkown |
| HY-175097 | AL 8810 Ethyl amide | / | Unkown | |
| HY-175862 | ALR2-IN-9 | / | Unkown | |
| HY-182202 | CAT Trimer phosphoramidite | / | Unkown | |
| HY-182621 | MB4253 | Inhibitor | / | Unkown |
| HY-183176 | Laurolinium acetate | Inhibitor | / | Unkown |
| HY-183840 | PP185 | Substrate | / | Unkown |
| HY-184084 | Antiparasitic agent-45 | Inhibitor | / | Unkown |
| HY-184085 | Antiparasitic agent-46 | / | Unkown | |
| HY-184308 | Antifungal agent-165 | / | Unkown | |
| HY-186081 | Ramiprilat acyl-β-D-glucuronide | / | Unkown | |
| HY-23317 | N-Methyl-4-(8-phenoxyoctoxy)aniline | Inhibitor | / | Unkown |
| HY-32350S1 | Ercalcitriol-d3 | Activator | / | Unkown |
| HY-B2035R | Pretilachlor (Standard) | / | Unkown | |
| HY-N3989 | Haplopine | 99.49% | Unkown | |
| HY-N7773 | Hibiscetin | / | Unkown | |
| HY-N8955 | Maritimein | / | Unkown | |
| HY-N9928 | Echinenone | Inhibitor | / | Unkown |
| HY-RS16665 | Cat Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS16943 | Trpv6 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS19300 | Mip Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23100 | Cat Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W008952 | Tributyltetradecyl phosphonium chloride | / | Unkown | |
| HY-W035445 | Antiparasitic agent-42 | Inhibitor | / | Unkown |
| HY-W108381 | Pyriprole | / | Unkown | |
| HY-W654254 | Malachite green-d5 oxalate | / | Unkown | |
| HY-W658325 | P-Decyloxyaniline | / | Unkown | |
| HY-W715812 | Bromuconazole | / | Unkown | |
| HY-W747601 | Chlorphoxim | / | Unkown | |
| HY-W751579 | Cefovecin | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99627 | Frunevetmab | 95.00% | Unkown | |
| HY-P99695 | Lerdelimumab | Inhibitor | / | Unkown |
| HY-P990562 | CAT-2200 | / | Unkown | |
| HY-P991906 | TRPH-222 Antibody | / | Unkown | |
| HY-P992011 | CAT-07 | Inhibitor | / | Unkown |